Fri, May
86 New Articles

B2RLaw and SSW Advise on Auxilius Pharma Investment Round

B2RLaw and SSW Advise on Auxilius Pharma Investment Round

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

B2RLaw has advised Auxilius Pharma and its founders on receiving investments from venture capital investors CofounderZone Corporate Angel Fund ASI and Augebit together with several business angels and existing investors. SSW Pragmatic Solutions advised CofounderZone.

According to B2RLaw, "with the new funds, the company will be able to further develop its flagship project involving the introduction of a value-added medication cardiological drug to the US market, as well as other drug development projects."

Auxilius Pharma is an early-stage pharmaceutical company. The company focuses on the development of cardiovascular medicine. According to a company statement, the round amounted to "roughly a total of USD 1 million."

CofounderZone is a Warsaw-headquartered investment fund that supports start-ups.

The B2RLaw team was led by Senior Associate Krystyna Jakubowska and included Senior Partner Rafal Stroinski, Senior Associate Teresa Pilecka-Juda, and Junior Associate Magdalena Zawislak.

The SSW team was led by Partner Katarzyna Solarz-Wlodarska and included Associate Mateusz Prochnicki.

Our Latest Issue